Executive Summary
SciDev Limited engages in the manufacture and supply of chemicals, technology, and services for industrial processes in Australia and the United States. More Details
Rewards
Risk Analysis
Snowflake Analysis
Excellent balance sheet with high growth potential.
Similar Companies
Share Price & News
How has SciDev's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SDV is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: SDV's weekly volatility (8%) has been stable over the past year.
Market Performance
7 Day Return
-6.9%
SDV
-5.2%
AU Chemicals
-1.1%
AU Market
1 Year Return
4.9%
SDV
1.5%
AU Chemicals
35.1%
AU Market
Return vs Industry: SDV exceeded the Australian Chemicals industry which returned 1.5% over the past year.
Return vs Market: SDV underperformed the Australian Market which returned 35.1% over the past year.
Shareholder returns
| SDV | Industry | Market | |
|---|---|---|---|
| 7 Day | -6.9% | -5.2% | -1.1% |
| 30 Day | -16.8% | -7.8% | -1.0% |
| 90 Day | 7.2% | -6.1% | 2.4% |
| 1 Year | 4.9%4.9% | 2.5%1.5% | 39.5%35.1% |
| 3 Year | 1,236.2%1,141.7% | -25.1%-28.4% | 30.1%14.6% |
| 5 Year | 1,236.2%1,141.7% | -7.3%-15.9% | 62.2%30.9% |
Long-Term Price Volatility Vs. Market
How volatile is SciDev's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall St
What You Need To Know About SciDev Limited's (ASX:SDV) Investor Composition3 months ago | Simply Wall St
Have Insiders Been Buying SciDev Limited (ASX:SDV) Shares?8 months ago | Simply Wall St
Are Insiders Buying SciDev Limited (ASX:SDV) Stock?Valuation
Is SciDev undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SDV (A$0.75) is trading below our estimate of fair value (A$3.81)
Significantly Below Fair Value: SDV is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: SDV is unprofitable, so we can't compare its PE Ratio to the Australian Chemicals industry average.
PE vs Market: SDV is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SDV's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SDV is overvalued based on its PB Ratio (4.6x) compared to the AU Chemicals industry average (3.3x).
Future Growth
How is SciDev forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
95.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SDV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).
Earnings vs Market: SDV is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SDV's is expected to become profitable in the next 3 years.
Revenue vs Market: SDV's revenue (41.4% per year) is forecast to grow faster than the Australian market (4.9% per year).
High Growth Revenue: SDV's revenue (41.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SDV's Return on Equity is forecast to be low in 3 years time (19.6%).
Past Performance
How has SciDev performed over the past 5 years?
-10.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SDV is currently unprofitable.
Growing Profit Margin: SDV is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SDV is unprofitable, and losses have increased over the past 5 years at a rate of 10.4% per year.
Accelerating Growth: Unable to compare SDV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SDV is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (18.5%).
Return on Equity
High ROE: SDV has a negative Return on Equity (-1.04%), as it is currently unprofitable.
Financial Health
How is SciDev's financial position?
Financial Position Analysis
Short Term Liabilities: SDV's short term assets (A$16.7M) exceed its short term liabilities (A$7.4M).
Long Term Liabilities: SDV's short term assets (A$16.7M) exceed its long term liabilities (A$364.9K).
Debt to Equity History and Analysis
Debt Level: SDV's debt to equity ratio (3.7%) is considered satisfactory.
Reducing Debt: SDV's debt to equity ratio has reduced from 11.1% to 3.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SDV has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SDV has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Dividend
What is SciDev current dividend yield, its reliability and sustainability?
0.89%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SDV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SDV's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SDV's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SDV's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SDV's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.1yrs
Average management tenure
CEO
Lewis Utting
2.08yrs
Tenure
AU$565,790
Compensation
Mr. Lewis Edward Utting, BASc is an Executive Director at SciDev Ltd since October 29, 2018 and has been its Chief Executive Officer and Managing Director since April 30, 2019. Mr. Utting has experience in...
CEO Compensation Analysis
Compensation vs Market: Lewis's total compensation ($USD439.86K) is above average for companies of similar size in the Australian market ($USD289.08K).
Compensation vs Earnings: Lewis's compensation has increased whilst the company is unprofitable.
Leadership Team
Experienced Management: SDV's management team is considered experienced (2.1 years average tenure).
Board Members
Experienced Board: SDV's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.7%.
Top Shareholders
Company Information
SciDev Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: SciDev Limited
- Ticker: SDV
- Exchange: ASX
- Founded: 2001
- Industry: Commodity Chemicals
- Sector: Materials
- Market Cap: AU$114.186m
- Shares outstanding: 153.27m
- Website: https://www.scidev.com.au
Location
- SciDev Limited
- 48 Atchison Street
- Suite 105
- St Leonards
- New South Wales
- 2065
- Australia
Listings
Biography
SciDev Limited engages in the manufacture and supply of chemicals, technology, and services for industrial processes in Australia and the United States. It offers coagulants and flocculants in powder and l...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/05/16 08:09 |
| End of Day Share Price | 2021/05/14 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.